SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
+2.05%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$151M
AUM Growth
+$151M
(+19%)
Cap. Flow
+$27.5M
Cap. Flow
% of AUM
18.15%
Top 10 Holdings %
Top 10 Hldgs %
90.44%
Holding
21
New
3
Increased
4
Reduced
2
Closed
–
Top Buys
1 |
BCEL
Atreca, Inc. Class A Common Stock
BCEL
|
$11.1M |
2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$9.53M |
3 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$5.88M |
4 |
HOOK
HOOKIPA Pharma
HOOK
|
$3.57M |
5 |
RGLS
Regulus Therapeutics
RGLS
|
$1.13M |
Top Sells
1 |
Gossamer Bio
GOSS
|
$3.47M |
2 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$1.19M |
Sector Composition
1 | Healthcare | 99.98% |